Global Nuclear Medicine Equipment Market by Type (Gamma Cameras, Cyclotrons, PET Scanners, SPECT Scanners), by Application (Oncology, Cardiology, Neurology, Orthopedics, Infectious Diseases), by End-Use Industry (Hospitals, Diagnostic Centers, Research & Academic Institutions) and By Region: Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Nuclear Medicine Equipment Market was valued at USD 5.1 Billion in 2024-e and will surpass USD 8.5 Billion by 2030; growing at a CAGR of 9.0% during 2025 - 2030.

The nuclear medicine equipment market is integral to the diagnosis and treatment of a wide range of medical conditions, offering non-invasive imaging techniques that allow for the visualization of the structure and function of organs and tissues. Using small amounts of radioactive materials (radiopharmaceuticals), nuclear medicine enables early detection of diseases, such as cancer, heart disease, and neurological disorders. The market for nuclear medicine equipment includes key technologies such as gamma cameras, cyclotrons, PET scanners, and SPECT scanners, which are crucial tools for the growing demand for accurate diagnostics in clinical settings. As medical imaging technology continues to evolve, nuclear medicine is becoming increasingly sophisticated, contributing to improved diagnostic accuracy and patient outcomes.

The market's growth is driven by factors such as the rising incidence of chronic diseases, advancements in imaging technologies, and increased investment in research and healthcare infrastructure. Furthermore, the rising adoption of personalized medicine and the ability to detect diseases at an earlier stage, particularly cancers and cardiac disorders, is further pushing the demand for nuclear medicine equipment. As healthcare systems globally continue to emphasize early diagnosis and targeted treatments, the nuclear medicine equipment market is expected to experience significant growth in the coming years.

Gamma Cameras Are Largest Technology Segment Due to Widely Established Applications

Gamma cameras are the largest technology segment in the nuclear medicine equipment market due to their long-established use in clinical settings for imaging a variety of diseases. These cameras are commonly used for imaging organs such as the heart, bones, and thyroid and play a crucial role in the diagnosis of conditions like cancer, cardiovascular diseases, and bone disorders. Gamma cameras work by detecting gamma rays emitted by radiopharmaceuticals introduced into the body, allowing for the visualization of the distribution of the radioactive material within tissues.

The widespread adoption of gamma cameras across hospitals, diagnostic centers, and research institutions has made them the most prevalent nuclear medicine technology. Their ability to provide detailed images of organs and detect functional abnormalities, such as tumor detection or heart blockages, has solidified their place as a key diagnostic tool in the medical community. Despite the growing competition from other imaging technologies like PET and SPECT, gamma cameras remain the largest segment, largely due to their cost-effectiveness, reliability, and versatility in clinical applications.

Nuclear Medicine Equipment Market Size

Oncology Is Largest Application Segment Due to Increasing Cancer Prevalence and Early Detection Focus

Oncology is the largest application segment in the nuclear medicine equipment market, driven by the rising global incidence of cancer and the increasing emphasis on early detection and treatment. Nuclear medicine plays a critical role in oncology, especially in detecting cancers at early stages, determining the extent of disease spread, and monitoring the effectiveness of therapies. Imaging techniques such as PET and SPECT scanners are widely used in oncology to detect and diagnose tumors, assess treatment response, and help in staging cancers.

The growing demand for nuclear medicine in oncology is supported by the increasing prevalence of various cancers, including breast, lung, and prostate cancer. As cancer treatment strategies shift towards personalized medicine, early-stage diagnosis becomes crucial for tailoring therapies that offer the best patient outcomes. The ability of nuclear medicine equipment to detect cancerous growths with high accuracy, combined with the rising number of cancer cases worldwide, positions oncology as the largest application segment in the nuclear medicine equipment market.

Hospitals Are Largest End-Use Industry Due to High Patient Volume and Diagnostic Demand

Hospitals are the largest end-use industry for nuclear medicine equipment, driven by the high volume of patients requiring advanced diagnostic services. Hospitals are key healthcare providers for various medical conditions, and nuclear medicine plays a vital role in diagnosing a wide range of diseases, including cancer, heart disease, and neurological disorders. The demand for nuclear medicine equipment in hospitals is fueled by the increasing number of patients with chronic conditions that require advanced diagnostic techniques.

Hospitals are equipped with state-of-the-art nuclear medicine technology, which is used for non-invasive imaging that provides valuable insights for accurate diagnosis and treatment planning. Additionally, hospitals often serve as the primary centers for cancer care, cardiology, and neurology, all of which are major applications of nuclear medicine. As hospitals continue to adopt new technologies to improve patient care and optimize treatment outcomes, they remain the largest end-use industry for nuclear medicine equipment, with steady demand for imaging systems.

North America Region Is Largest Market Due to Advanced Healthcare Infrastructure and High Demand

North America is the largest region in the nuclear medicine equipment market, driven by the advanced healthcare infrastructure, high healthcare spending, and rapid adoption of cutting-edge imaging technologies. The U.S. and Canada are leaders in medical research and diagnostics, and the region’s hospitals, diagnostic centers, and research institutions are major consumers of nuclear medicine equipment. North America is also home to some of the world’s leading manufacturers of nuclear medicine equipment, and the region benefits from strong regulatory frameworks that support the use of advanced diagnostic tools.

The growing focus on personalized medicine and early-stage disease detection in North America has resulted in an increased demand for nuclear imaging technologies, particularly in oncology, cardiology, and neurology. The region’s leadership in medical research and investment in healthcare infrastructure ensures that North America remains the largest market for nuclear medicine equipment, with the demand for advanced diagnostic imaging technologies expected to continue growing.

Nuclear Medicine Equipment Market Size by Region 2030

Competitive Landscape and Key Players

The nuclear medicine equipment market is competitive, with several key players dominating the industry. Major companies in the market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems, all of which offer a range of nuclear medicine imaging systems, such as gamma cameras, PET scanners, and SPECT scanners. These companies have a strong presence in the market, offering innovative solutions to meet the growing demand for accurate diagnostic tools.

The competitive landscape is characterized by significant investments in research and development, with key players focusing on enhancing the capabilities of their imaging systems and incorporating advancements like artificial intelligence to improve diagnostic accuracy. The market is also influenced by collaborations and partnerships between manufacturers, hospitals, and research institutions to develop more advanced nuclear medicine technologies. As the market for nuclear medicine equipment continues to expand, companies will need to stay ahead by offering innovative solutions that cater to the evolving needs of healthcare providers, particularly in oncology and cardiology.

Recent Developments:

  • Siemens Healthineers launched a new gamma camera with advanced imaging capabilities, enhancing the accuracy of detecting early-stage cancers and improving treatment outcomes.
  • GE Healthcare received FDA approval for its latest PET scanner, designed to offer higher resolution imaging and reduced scan times, improving patient throughput and diagnostic precision.
  • Philips Healthcare announced the development of a next-generation SPECT scanner that integrates artificial intelligence for faster, more accurate diagnosis of heart disease and neurological conditions.
  • Medtronic introduced a state-of-the-art cyclotron system that enables the on-site production of radiopharmaceuticals, reducing the reliance on external supply chains for nuclear medicine imaging.
  • United Imaging Healthcare secured a strategic partnership with major hospitals to roll out its advanced nuclear medicine equipment for cancer and cardiovascular imaging.

List of Leading Companies:

  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems Corporation
  • Medtronic
  • Toshiba Medical Systems Corporation
  • Hitachi Medical Corporation
  • Neusoft Medical Systems Co., Ltd.
  • United Imaging Healthcare Co., Ltd.
  • Carestream Health
  • Spectrum Dynamics Medical
  • Mirada Medical
  • Best Medical International
  • Nuvia Medical
  • Radiation Detection Systems

Report Scope:

Report Features

Description

Market Size (2024-e)

USD 5.1 Billion

Forecasted Value (2030)

USD 8.5 Billion

CAGR (2025 – 2030)

9.0%

Base Year for Estimation

2024-e

Historic Year

2023

Forecast Period

2025 – 2030

Report Coverage

Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments

Segments Covered

Global Nuclear Medicine Equipment Market by Type (Gamma Cameras, Cyclotrons, PET Scanners, SPECT Scanners), by Application (Oncology, Cardiology, Neurology, Orthopedics, Infectious Diseases), by End-Use Industry (Hospitals, Diagnostic Centers, Research & Academic Institutions)

Regional Analysis

North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa)

Major Companies

Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corporation, Medtronic, Toshiba Medical Systems Corporation, Neusoft Medical Systems Co., Ltd., United Imaging Healthcare Co., Ltd., Carestream Health, Spectrum Dynamics Medical, Mirada Medical, Best Medical International, Radiation Detection Systems

Customization Scope

Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements

1. Introduction

   1.1. Market Definition

   1.2. Scope of the Study

   1.3. Research Assumptions

   1.4. Study Limitations

2. Research Methodology

   2.1. Research Approach

      2.1.1. Top-Down Method

      2.1.2. Bottom-Up Method

      2.1.3. Factor Impact Analysis

  2.2. Insights & Data Collection Process

      2.2.1. Secondary Research

      2.2.2. Primary Research

   2.3. Data Mining Process

      2.3.1. Data Analysis

      2.3.2. Data Validation and Revalidation

      2.3.3. Data Triangulation

3. Executive Summary

   3.1. Major Markets & Segments

   3.2. Highest Growing Regions and Respective Countries

   3.3. Impact of Growth Drivers & Inhibitors

   3.4. Regulatory Overview by Country

4. Nuclear Medicine Equipment Market, by Type (Market Size & Forecast: USD Million, 2023 – 2030)

   4.1. Gamma Cameras

   4.2. Cyclotrons

   4.3. PET Scanners

   4.4. SPECT Scanners

5. Nuclear Medicine Equipment Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030)

   5.1. Oncology

   5.2. Cardiology

   5.3. Neurology

   5.4. Orthopedics

   5.5. Infectious Diseases

6. Nuclear Medicine Equipment Market, by End-Use Industry (Market Size & Forecast: USD Million, 2023 – 2030)

   6.1. Hospitals

   6.2. Diagnostic Centers

   6.3. Research & Academic Institutions

7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030)

   7.1. Regional Overview

   7.2. North America

      7.2.1. Regional Trends & Growth Drivers

      7.2.2. Barriers & Challenges

      7.2.3. Opportunities

      7.2.4. Factor Impact Analysis

      7.2.5. Technology Trends

      7.2.6. North America Nuclear Medicine Equipment Market, by Type

      7.2.7. North America Nuclear Medicine Equipment Market, by Application

      7.2.8. North America Nuclear Medicine Equipment Market, by End-Use Industry

      7.2.9. By Country

         7.2.9.1. US

               7.2.9.1.1. US Nuclear Medicine Equipment Market, by Type

               7.2.9.1.2. US Nuclear Medicine Equipment Market, by Application

               7.2.9.1.3. US Nuclear Medicine Equipment Market, by End-Use Industry

         7.2.9.2. Canada

         7.2.9.3. Mexico

    *Similar segmentation will be provided for each region and country

   7.3. Europe

   7.4. Asia-Pacific

   7.5. Latin America

   7.6. Middle East & Africa

8. Competitive Landscape

   8.1. Overview of the Key Players

   8.2. Competitive Ecosystem

      8.2.1. Level of Fragmentation

      8.2.2. Market Consolidation

      8.2.3. Product Innovation

   8.3. Company Share Analysis

   8.4. Company Benchmarking Matrix

      8.4.1. Strategic Overview

      8.4.2. Product Innovations

   8.5. Start-up Ecosystem

   8.6. Strategic Competitive Insights/ Customer Imperatives

   8.7. ESG Matrix/ Sustainability Matrix

   8.8. Manufacturing Network

      8.8.1. Locations

      8.8.2. Supply Chain and Logistics

      8.8.3. Product Flexibility/Customization

      8.8.4. Digital Transformation and Connectivity

      8.8.5. Environmental and Regulatory Compliance

   8.9. Technology Readiness Level Matrix

   8.10. Technology Maturity Curve

   8.11. Buying Criteria

9. Company Profiles

   9.1. Siemens Healthineers

      9.1.1. Company Overview

      9.1.2. Company Financials

      9.1.3. Product/Service Portfolio

      9.1.4. Recent Developments

      9.1.5. IMR Analysis

    *Similar information will be provided for other companies 

   9.2. GE Healthcare

   9.3. Philips Healthcare

   9.4. Canon Medical Systems Corporation

   9.5. Medtronic

   9.6. Toshiba Medical Systems Corporation

   9.7. Hitachi Medical Corporation

   9.8. Neusoft Medical Systems Co., Ltd.

   9.9. United Imaging Healthcare Co., Ltd.

   9.10. Carestream Health

   9.11. Spectrum Dynamics Medical

   9.12. Mirada Medical

   9.13. Best Medical International

   9.14. Nuvia Medical

   9.15. Radiation Detection Systems

10. Appendix

A comprehensive market research approach was employed to gather and analyze data on the Nuclear Medicine Equipment Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Nuclear Medicine Equipment Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.

Research Approach -

Secondary Research

Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.

Primary Research

Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:

  • Validating findings and assumptions derived from secondary research
  • Gathering qualitative and quantitative data on market trends, drivers, and challenges
  • Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
  • Assessing the supply-side landscape, including technological advancements and recent developments

Market Size Assessment

A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Nuclear Medicine Equipment Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:

  1. Identification of key industry players and relevant revenues through extensive secondary research
  2. Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
  3. Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources

Bottom Up and Top Down -

Data Triangulation

To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.

NA

Please state your requirements.

  • United States+1
  • United Kingdom+44
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua and Barbuda+1
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1
  • Bahrain (‫البحرين‬‎)+973
  • Barbados+1
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • Northern Mariana Islands+1
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1
  • Saint Lucia+1
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358

I have read the Terms & Conditions and Privacy Policy. I agree to its terms.

Report Buying Options